Gibbs Michael Terrence
- SEC CIK
- 0001665000
No open-market purchases or sales filed in the past year.
Current role at each company
- TTOO T2 Biosystems, Inc.General Counselas of Jan 2, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Gibbs Michael Terrence as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 6, 2023 (view filing)1:08 PM ET | Mar 28 | 9 daysLate | Gibbs Michael TerrenceGeneral Counsel | SSale | −239 | $0.481 | −$114.96 | −3.5%6.61K after | |
| Mar 9, 2023 (view filing) | Feb 22-28 | 15 daysLate | Gibbs Michael TerrenceGeneral Counsel | SSale | −3.73K | $0.6245 | −$2.33K | −36.4%6.52K after | 2 lots |
| Apr 11, 2022 (view filing)9:50 AM ET | Apr 7 | 4 days | Gibbs Michael TerrenceGeneral Counsel | PPurchase | +10.0K | $0.49 | +$4.90K | +6.4%166.7K after |